Simplify Logo

Full-Time

Senior Director

Vendor Outsourcing

Posted on 6/27/2024

Pliant Therapeutics

Pliant Therapeutics

51-200 employees

Develops treatments for fibrotic diseases

Hardware
Biotechnology

Compensation Overview

$240k - $250kAnnually

+ Equity + Bonus

Expert

San Bruno, CA, USA

Category
Procurement & Sourcing
Operations & Logistics
Required Skills
Management
Excel/Numbers/Sheets
Requirements
  • 15+ years of relevant clinical development experience preferred with a B.A./B.S. degree; or 12+ years of relevant clinical development experience preferred with an advanced degree.
  • 5+ years of experience directly negotiating full scope CRO agreements at task and resource by region level and/or building CRO resourcing models.
  • 5+ years of functional management experience preferred.
  • 5+ years people management experience preferred.
  • 2+ years of experience with site budget development utilizing fair-market value standards preferred.
  • Ability to utilize complex Microsoft Excel formulas and functions – e.g. VLOOKUP, INDEX, MATCH and pivots.
  • Experience with writing macros or other programming languages a plus.
Responsibilities
  • Setting the vision for and developing and enhancing the standards, processes and tools utilized by Vendor Outsourcing in support of the CDO.
  • Leading the vendor selection lifecycle including Request-for-Information (RFI) and/or Request-for-Proposal (RFP) activities for clinical services such as study management (CROs), central laboratory, bioanalytical services, interactive response technology (IRT), etc.
  • Leading the review and negotiation of budgets for CRO, central laboratory and other vendor agreements.
  • In collaboration with Legal, negotiating vendor agreements including payment terms in accordance with Pliant standards and processes.
  • Developing and maintaining strategic partnerships with key vendors to enable effective collaboration and issue resolution.
  • Supporting the budget forecasting activities and quarterly financial reviews with Clinical Operations and Corporate Finance.
  • Effectively partnering with relevant internal and external stakeholders such as Clinical Operations, Legal, Regulatory, Finance, Quality Assurance and/or vendors, as applicable, to enable informed, risk-considered decisions.
  • Proactively identifying, defining and implementing new or improved departmental processes or standards.
  • Leading and managing a forthcoming team of Business Operations professionals.

Pliant Therapeutics develops treatments for fibrotic diseases, which cause thickening and scarring of connective tissue, leading to organ dysfunction. Their products work by targeting the biological mechanisms behind fibrosis, particularly through the inhibition of integrins, which are proteins that help cells stick together and communicate. This targeted approach allows Pliant to create effective treatments for various fibrotic conditions. Unlike many competitors, Pliant focuses specifically on the science of fibrosis and integrin biology, aiming to reverse the effects of these diseases rather than just manage symptoms. The company's goal is to halt the progression of fibrotic diseases and restore normal organ function, ultimately improving the quality of life for patients.

Company Stage

IPO

Total Funding

$694.9M

Headquarters

San Francisco, California

Founded

2015

Growth & Insights
Headcount

6 month growth

12%

1 year growth

17%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Pliant's accelerated development of bexotegrast for IPF and positive Phase 2a trial results indicate strong potential for successful market entry.
  • The company's participation in high-profile investor events and scientific congresses enhances its visibility and credibility in the biotech community.
  • Recent strategic appointments, including a new Chief Development Officer and Chief Regulatory Officer, bolster Pliant's leadership team and operational capabilities.

What critics are saying

  • The high costs and long timelines associated with drug development pose financial risks, especially if clinical trials do not meet endpoints.
  • The competitive landscape in biopharmaceuticals, particularly in fibrosis treatment, requires Pliant to continuously innovate to maintain its edge.

What makes Pliant Therapeutics unique

  • Pliant Therapeutics focuses specifically on fibrotic diseases, leveraging deep expertise in fibrosis and integrin biology, unlike competitors with broader therapeutic areas.
  • Their targeted approach to integrin inhibition offers a unique mechanism of action that sets them apart from other fibrosis treatments.
  • Pliant's commitment to rigorous clinical trials and data-driven development ensures high standards of efficacy and safety, distinguishing them in the biopharmaceutical market.
INACTIVE